Literature DB >> 11999214

The EGF/ErbB receptor family and apoptosis.

Andrew J Danielsen1, Nita J Maihle.   

Abstract

The ErbB receptor family can activate a multitude of cell signaling pathways that involve many aspects of cellular function. The four members of the ErbB receptor family interact with diverse ligands and substrates, as well as with each other through cell surface heterodimerization. The sum of these diverse interactions is a signaling network that is complex but also finely regulated. Among the cellular functions influenced by ErbB signaling is cell survival. ErbB receptor signaling has been demonstrated to interact with all of the major mechanisms of cell death signaling in a manner that promotes cell survival. Survival factors such as Ras, PI3-K, Akt, and Bcl-x/-2 all have been shown to be activated by ErbB signaling (Fig. 5). ErbB abrogation of apoptotic signals has been shown to play an important role during embryonic tissue development, in normal adult tissue maintenance (e.g. mammary tissue, wound healing), and also in tumor development and progression. Although the majority of studies suggest that ErbB receptor family members are mediators of cell survival, there have been occasional reports suggesting that ErbB receptors can induce cell death under selected experimental conditions. While this apparent discrepancy remains unresolved, in many of these reports, cell death may be the result of anoikis in response to changes in the cytoskeleton associated with hyperstimulation of ErbB signaling. The notion that ErbB receptor family members function to promote cell survival is not a recent observation. However, how this family functions to prevent apoptosis is an area that only recently has been considered. The understanding of ErbB receptor signaling as it relates to the avoidance of apoptosis had profound implications for the treatment of solid tumors originating in multiple tissues, as well as for the treatment of neurodegenerative disease. Further elucidation of the complex relationships between ErbB receptor signaling networks and the apoptotic machinery is certain to yield biologically important and potentially life-saving information.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11999214     DOI: 10.1080/08977190290022185

Source DB:  PubMed          Journal:  Growth Factors        ISSN: 0897-7194            Impact factor:   2.511


  23 in total

Review 1.  Novel agents for chemoprevention, screening methods, and sampling issues.

Authors:  Mary Jo Fackler; Ella Evron; Seema A Khan; Saraswati Sukumar
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-01       Impact factor: 2.673

2.  Interaction of tumor necrosis alpha - G308A and epidermal growth factor gene polymorphisms in early-onset schizophrenia.

Authors:  Olli Kampman; Sami Anttila; Ari Illi; Kari M Mattila; Riikka Rontu; Esa Leinonen; Terho Lehtimäki
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2004-12-24       Impact factor: 5.270

3.  The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment.

Authors:  Hilary F Clark; Austin L Gurney; Evangeline Abaya; Kevin Baker; Daryl Baldwin; Jennifer Brush; Jian Chen; Bernard Chow; Clarissa Chui; Craig Crowley; Bridget Currell; Bethanne Deuel; Patrick Dowd; Dan Eaton; Jessica Foster; Christopher Grimaldi; Qimin Gu; Philip E Hass; Sherry Heldens; Arthur Huang; Hok Seon Kim; Laura Klimowski; Yisheng Jin; Stephanie Johnson; James Lee; Lhney Lewis; Dongzhou Liao; Melanie Mark; Edward Robbie; Celina Sanchez; Jill Schoenfeld; Somasekar Seshagiri; Laura Simmons; Jennifer Singh; Victoria Smith; Jeremy Stinson; Alicia Vagts; Richard Vandlen; Colin Watanabe; David Wieand; Kathryn Woods; Ming-Hong Xie; Daniel Yansura; Sothy Yi; Guoying Yu; Jean Yuan; Min Zhang; Zemin Zhang; Audrey Goddard; William I Wood; Paul Godowski; Alane Gray
Journal:  Genome Res       Date:  2003-09-15       Impact factor: 9.043

Review 4.  Physiology of the read-write genome.

Authors:  James A Shapiro
Journal:  J Physiol       Date:  2014-06-01       Impact factor: 5.182

5.  TNF-α converting enzyme-mediated ErbB4 transactivation by TNF promotes colonic epithelial cell survival.

Authors:  Valda C Hilliard; Mark R Frey; Peter J Dempsey; Richard M Peek; D Brent Polk
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-05-26       Impact factor: 4.052

Review 6.  Epigenetic modifications and self-renewal regulation of mouse germline stem cells.

Authors:  Jiyoung Lee; Takashi Shinohara
Journal:  Cell Res       Date:  2011-07-12       Impact factor: 25.617

7.  Cell surface beta 1, 4-galactosyltransferase 1 promotes apoptosis by inhibiting epidermal growth factor receptor pathway.

Authors:  Zejuan Li; Hongliang Zong; Xiangfei Kong; Si Zhang; Hanzhou Wang; Qing Sun; Jianxin Gu
Journal:  Mol Cell Biochem       Date:  2006-06-20       Impact factor: 3.396

8.  Epidermal growth factor triggers an original, caspase-independent pituitary cell death with heterogeneous phenotype.

Authors:  Joanna Fombonne; Stéphanie Reix; Ramahefarizo Rasolonjanahary; Emmanuelle Danty; Sylvie Thirion; Geneviéve Laforge-Anglade; Olivier Bosler; Patrick Mehlen; Alain Enjalbert; Slavica Krantic
Journal:  Mol Biol Cell       Date:  2004-08-25       Impact factor: 4.138

9.  Gene alteration of intestinal intraepithelial lymphocytes in response to massive small bowel resection.

Authors:  Barbara E Wildhaber; Hua Yang; Arnold G Coran; Daniel H Teitelbaum
Journal:  Pediatr Surg Int       Date:  2003-05-01       Impact factor: 1.827

10.  The EGF 61A/G polymorphism - a predictive marker for recurrence of liver metastases from colorectal cancer.

Authors:  Florian M Kovar; Christiane Thallinger; Claudia L Marsik; Thomas Perkmann; Harald Puhalla; Helmuth Haslacher; Fritz Wrba; Oswald F Wagner; Thomas Gruenberger; Georg Endler
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.